Evidence map›Paper›PMID 35822611›Full record

ArticleToxicological sciences : an official journal of the Society of Toxicology2022

Are Non-animal Systemic Safety Assessments Protective? A Toolbox and Workflow.

Alistair M Middleton, Joe Reynolds, Sophie Cable, Maria Teresa Baltazar, Hequn Li, Samantha Bevan, Paul L Carmichael, Matthew Philip Dent, Sarah Hatherell, Jade Houghton and 10 more

Open access · hybridAbstract read
In one paragraph

Article in Toxicological sciences : an official journal of the Society of Toxicology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
12.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Advancing systemic toxicity risk assessment: Evaluation of a NAM-based toolbox approach.Toxicological sciences : an official journal of the Society of Toxicology · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Enabling novel paradigms: a biological questions-based approach to human chemical hazard and drug safety assessment.Toxicological sciences : an official journal of the Society of Toxicology · 2024
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 3 institutions in 1 country.

Alistair M MiddletonUnilever Safety and Environmental Assurance Centre, Bedfordshire MK44 1LQ, UK.ORCID 0000-0002-9508-4117
Joe ReynoldsUnilever Safety and Environmental Assurance Centre, Bedfordshire MK44 1LQ, UK.
Sophie CableUnilever Safety and Environmental Assurance Centre, Bedfordshire MK44 1LQ, UK.
Maria Teresa BaltazarUnilever Safety and Environmental Assurance Centre, Bedfordshire MK44 1LQ, UK.
Hequn LiUnilever Safety and Environmental Assurance Centre, Bedfordshire MK44 1LQ, UK.ORCID 0000-0002-5529-9236
Samantha BevanCyprotex Discovery Ltd, Cheshire SK10 4TG, UK.
Paul L CarmichaelUnilever Safety and Environmental Assurance Centre, Bedfordshire MK44 1LQ, UK.
Matthew Philip DentUnilever Safety and Environmental Assurance Centre, Bedfordshire MK44 1LQ, UK.
Sarah HatherellUnilever Safety and Environmental Assurance Centre, Bedfordshire MK44 1LQ, UK.
Jade HoughtonUnilever Safety and Environmental Assurance Centre, Bedfordshire MK44 1LQ, UK.
Predrag KukicUnilever Safety and Environmental Assurance Centre, Bedfordshire MK44 1LQ, UK.
Mark LiddellUnilever Safety and Environmental Assurance Centre, Bedfordshire MK44 1LQ, UK.
Sophie MalcomberUnilever Safety and Environmental Assurance Centre, Bedfordshire MK44 1LQ, UK.
Beate NicolUnilever Safety and Environmental Assurance Centre, Bedfordshire MK44 1LQ, UK.
Benjamin ParkCyprotex Discovery Ltd, Cheshire SK10 4TG, UK.
Hiral PatelCharles River Laboratories, Cambridgeshire, CB10 1XL, UK.
Sharon ScottUnilever Safety and Environmental Assurance Centre, Bedfordshire MK44 1LQ, UK.
Chris SparhamUnilever Safety and Environmental Assurance Centre, Bedfordshire MK44 1LQ, UK.
Paul WalkerCyprotex Discovery Ltd, Cheshire SK10 4TG, UK.ORCID 0000-0002-7840-9709
Andrew WhiteUnilever Safety and Environmental Assurance Centre, Bedfordshire MK44 1LQ, UK.
Unilever (United Kingdom) · GBC4X Discovery (United Kingdom) · GBCharles River Laboratories (United Kingdom) · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An important question in toxicological risk assessment is whether non-animal new approach methodologies (NAMs) can be used to make safety decisions that are protective of human health, without being overly conservative. In this work, we propose a core NAM toolbox and workflow for conducting systemic safety assessments for adult consumers. We also present an approach for evaluating how protective and useful the toolbox and workflow are by benchmarking against historical safety decisions. The toolbox includes physiologically based kinetic (PBK) models to estimate systemic Cmax levels in humans, and 3 bioactivity platforms, comprising high-throughput transcriptomics, a cell stress panel, and in vitro pharmacological profiling, from which points of departure are estimated. A Bayesian model was developed to quantify the uncertainty in the Cmax estimates depending on how the PBK models were parameterized. The feasibility of the evaluation approach was tested using 24 exposure scenarios from 10 chemicals, some of which would be considered high risk from a consumer goods perspective (eg, drugs that are systemically bioactive) and some low risk (eg, existing food or cosmetic ingredients). Using novel protectiveness and utility metrics, it was shown that up to 69% (9/13) of the low risk scenarios could be identified as such using the toolbox, whilst being protective against all (5/5) the high-risk ones. The results demonstrated how robust safety decisions could be made without using animal data. This work will enable a full evaluation to assess how protective and useful the toolbox and workflow are across a broader range of chemical-exposure scenarios.

Indexed as

CosmeticsAdultBayes TheoremBenchmarkingHumansRisk AssessmentWorkflowCosmeticsBayesian modellingnew approach methodologiesphysiologically based pharmacokineticspoint of departureprobabilistic risk assessment

Identifiers

PMID35822611
PMCPMC9412174
OpenAlexW4285392722

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.